$5.01
0.13[2.66%]
Last update: 2:49PM Get Real Time Here
Puma Biotechnology
(NASDAQ:PBYI)Puma Biotechnology Stock (NASDAQ:PBYI), Analyst Ratings, Price Targets, Predictions
Puma Biotechnology Inc has a consensus price target of $5.25, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 1, 2024, February 13, 2024, and September 20, 2023. With an average price target of $7.67 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 53.03% upside for Puma Biotechnology Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Citigroup
RBC Capital
Goldman Sachs
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Puma Biotechnology
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/01/2024 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 39.72% | HC Wainwright & Co. | Edward White | $8 → $7 | Maintains | Buy | Get Alert |
| 02/13/2024 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 59.68% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 09/20/2023 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 59.68% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 59.68% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 59.68% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2023 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 59.68% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 59.68% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 08/05/2022 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 59.68% | HC Wainwright & Co. | Edward White | $12 → $8 | Maintains | Buy | Get Alert |
| 05/06/2022 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 139.52% | HC Wainwright & Co. | Edward White | $14 → $12 | Maintains | Buy | Get Alert |
| 09/28/2021 | PBYI | Buy Now | Puma Biotechnology | $5.01 | — | Citigroup | — | — | Upgrade | Neutral → Buy | Get Alert |
| 08/06/2021 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 19.76% | RBC Capital | Kennen MacKay | — | Maintains | Sector Perform | Get Alert |
| 08/06/2021 | PBYI | Buy Now | Puma Biotechnology | $5.01 | 59.68% | Goldman Sachs | — | — | Maintains | Sell | Get Alert |
FAQ
What is the target price for Puma Biotechnology (PBYI)?
The latest price target for Puma Biotechnology (NASDAQ: PBYI) was reported by HC Wainwright & Co. on March 1, 2024. The analyst firm set a price target for $7.00 expecting PBYI to rise to within 12 months (a possible 39.72% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Puma Biotechnology (PBYI)?
The latest analyst rating for Puma Biotechnology (NASDAQ: PBYI) was provided by HC Wainwright & Co., and Puma Biotechnology maintained their buy rating.
When was the last upgrade for Puma Biotechnology (PBYI)?
The last upgrade for Puma Biotechnology Inc happened on September 28, 2021 when Citigroup raised their price target to N/A. Citigroup previously had a neutral for Puma Biotechnology Inc.
When was the last downgrade for Puma Biotechnology (PBYI)?
There is no last downgrade for Puma Biotechnology.
When is the next analyst rating going to be posted or updated for Puma Biotechnology (PBYI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Puma Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Puma Biotechnology was filed on March 1, 2024 so you should expect the next rating to be made available sometime around March 1, 2025.
Is the Analyst Rating Puma Biotechnology (PBYI) correct?
While ratings are subjective and will change, the latest Puma Biotechnology (PBYI) rating was a maintained with a price target of $8.00 to $7.00. The current price Puma Biotechnology (PBYI) is trading at is $5.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.